-
Belgian court suspends TotalEnergies climate trial
-
Troubled waters: Thai fishermen marooned by rising fuel costs
-
Doku adamant Man City still have plenty to play for after Champions League exit
-
Afghanistan vows to avenge deadly Kabul bombing but says open to talks
-
Nigerian president meets royals on 'historic' UK state visit
-
South Lebanon residents flee death and destruction
-
Buttler ready to continue England career despite 'poor' T20 World Cup
-
Why convoys cannot fully protect oil tankers from Iran attacks
-
UK PM leads efforts to halt deadly meningitis spread
-
EU lawmakers back ban on sexualised AI deepfakes
-
Stripping Senegal of AFCON title a 'disgrace for Africa' say fans
-
Under Hezbollah fire, people in north Israel hope for better days
-
Iran women's football team cross Turkish border to head home: AFP
-
Fear in central Beirut as Israel strikes, with and without warning
-
'France is wild': Macron to unveil name of Europe's largest warship
-
Arsenal's Trossard says Leverkusen win ideal ahead of League Cup final
-
Israel conducts wave of strikes on Beirut
-
Seven-year term sought for Norway princess's son for alleged rapes
-
US govt says Anthropic AI an 'unacceptable risk' to military
-
Head of victorious Nepal party hails 'win for the country'
-
UN maritime body kicks off emergency talks on Mideast shipping
-
Israel says killed Iran intel chief, tells military to hunt down officials
-
China tech giant Tencent bets on AI agents
-
AFCON stripping of Senegal's title a 'disgrace for Africa' say fans
-
Japan thrash South Korea 4-1 to set up Women's Asian Cup final with Australia
-
Fernandez uncertain over Chelsea future after Champions League exit
-
Iran women's football team arrive in eastern Turkey, heading home
-
Russia slams Oscar-winning anti-Putin documentary
-
Mass burials expected for victims of Kabul drug rehab centre strike
-
Celtic keeper Schmeichel fears shoulder injury could end his career
-
Israelis shelter with pets from threat of Iran missiles
-
Deadly strikes across Mideast as Iran vows revenge on slain security chief
-
Japan, S. Korea petrochemical industry slows output on Iran war
-
Chinese tourists ditch Japan for third month running
-
Record setters Duplantis, Hodgkinson headline Torun world indoors
-
Chinese visitors to Japan plunge 45.2% in February
-
BTS light stick prices surge ahead of comeback concert
-
'Special human' Slipper to break Super Rugby appearance record
-
Brussels to unveil 'EU Inc' pan-European company status
-
Iran to hold funeral for slain security chief as it vows vengeance
-
Greenland's teenage boxers throwing punches to survive
-
TotalEnergies faces ruling in Belgian farmer climate case
-
Brazil starts to restrict minors' access to social media
-
Trespasser caught in viral hippo Moo Deng's Thai zoo pen
-
Gilgeous-Alexander scores 40 as Thunder clinch playoff berth
-
Venezuela stun United States to win World Baseball Classic
-
Stocks extend gains and oil dips as US, Israel, Iran continue strikes
-
Iran missile fire kills two in central Israel: medics
-
Britain, Rwanda in £100m court clash over migrant deal
-
'We will wait for each one': Ukrainians greet POWs with tears and cheers
Moderna rebuked over plan to hike Covid vaccine to $130
Moderna's chief executive on Wednesday defended the US company's plan to quadruple the price of its lifesaving Covid vaccine to as much as $130 per dose as soon as government stockpiles run out.
Democratic Senator Bernie Sanders lashed out at the price hike, denouncing the "unprecedented level of corporate greed" in the pharmaceutical industry. "And that is certainly true with Moderna," Sanders said.
Moderna has so far charged between about $15 and $26 for doses of its vaccine, according to the Kaiser Family Foundation.
The US government subsidized $1.7 billion of Moderna's research at the start of the pandemic and then purchased $10 billion worth of vaccine, Sanders said at a Senate hearing where the company's CEO Stephane Bancel was testifying.
Sanders said Moderna was "thanking the taxpayers of the United States" by more than quadrupling the vaccine's price "at a time when it costs less than $3 to manufacture."
Sanders noted several times at the hearing that Moderna conducted buybacks of its own stock and paid its own executives at its Cambridge, Massachusetts, headquarters handsomely.
Bancel defended Moderna, saying the distribution system will change completely when the US government lifts a state of health emergency, perhaps as soon as May.
Up until now, Moderna had only one customer, distributed its vaccine to only a few warehouses and did not have to pay for the cost of expired doses.
By switching to a more traditional marketing approach, "we're going to have 10,000 customers" and have to "manage to deliver to 60,000 pharmacies, doctors' offices and hospitals," he added.
Currently distributed in multidose vials, the vaccine will be sold mostly in single-dose vials or directly in prefilled syringes. And Moderna will have to take care of the unsold doses.
The company expects a "90 percent reduction in demand," Bancel said. "We are losing economies of scale. We must assume the wastage risk and cost that the US government used to assume."
Moderna also pledged to set up a program so that the uninsured or underinsured would not have to pay anything.
When pressed by Sanders about the possibility of the company lowering its price for government-run health insurance programs, Bancel said discussions were underway with all customers.
P.Martin--AMWN